Literature DB >> 9285445

Paraneoplastic encephalomyelitis: an update of the effects of the anti-Hu immune response on the nervous system and tumour.

R D Voltz, J B Posner, J Dalmau, F Graus.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9285445      PMCID: PMC2169668          DOI: 10.1136/jnnp.63.2.133

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  7 in total

1.  Paraneoplastic sensorimotor neuropathy associated with regression of small cell lung carcinoma.

Authors:  E Mawhinney; O M Gray; F McVerry; G V McDonnell
Journal:  BMJ Case Rep       Date:  2010-10-03

2.  Phenotypic and neuropathologic heterogeneity of anti-Hu antibody-related paraneoplastic syndrome presenting with progressive dysautonomia: report of two cases.

Authors:  A S Winkler; A Dean; M Hu; N Gregson; K R Chaudhuri
Journal:  Clin Auton Res       Date:  2001-04       Impact factor: 4.435

3.  Synchronous Adie's syndrome and type 1 antineuronal nuclear antibody (anti-Hu)-related paraneoplastic neurological syndromes as predictors of complete response in limited-stage small-cell lung cancer: A case report.

Authors:  Katherina Bernadette Sreter; Blazenka Barisic; Marija Barisic Kutija; Suzana Kukulj; Miroslav Samarzija
Journal:  Mol Clin Oncol       Date:  2017-05-08

Review 4.  Small cell lung carcinoma presenting with acute disseminated encephalomyelitis.

Authors:  R Summerfield; A Al-Saleh; S E Robbins
Journal:  Br J Radiol       Date:  2010-03       Impact factor: 3.039

5.  The Roles of Radiotherapy and Immunotherapy for the Treatment of Lymphoma.

Authors:  Amy S Kimball; Tonya J Webb
Journal:  Mol Cell Pharmacol       Date:  2013-01-01

6.  Chemotherapy-induced polyneuropathy. Part I. Pathophysiology.

Authors:  Krzysztof Brzeziński
Journal:  Contemp Oncol (Pozn)       Date:  2012-02-29

Review 7.  Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy.

Authors:  Meleeneh Kazarian; Ite A Laird-Offringa
Journal:  Mol Cancer       Date:  2011-03-30       Impact factor: 27.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.